Ep. 318 How Rocket Lab And ASTS Are Creating Out-Of-This World Innovations

from Investing With IBD · host Investor's Business Daily

Spacing out a bit in a tumultuous market? Here’s why Andrew Chanin, CEO of ProcureAM is looking for otherworldly innovation in stocks like Rocket Lab and ASTS, even in a risk-on investing environment. But it’s not all about being starry-eyed: Chanin explains why other space-related names could see a rougher time ahead. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Apr 30, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 318 How Rocket Lab And ASTS Are Creating Out-Of-This World Innovations

0:00 46:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Investing With IBD?

This episode is 46 minutes long.

When was this Investing With IBD episode published?

This episode was published on April 30, 2025.

Can I download this Investing With IBD episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!